Abstract
FLAG-IDA and Ponatinib in Patients with Blast Phase Chronic Myeloid Leukaemia: Results from the Phase I/II UK Trials Acceleration Programme Matchpoint Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have